Scott Carmer
2021
In 2021, Scott Carmer earned a total compensation of $4.3M as President and Chief Executive Officer at NexImmune, a 730% increase compared to previous year.
Compensation breakdown
| Bonus | $195,700 |
|---|---|
| Option Awards | $3,587,386 |
| Salary | $509,210 |
| Other | $9,043 |
| Total | $4,301,339 |
Carmer received $3.6M in option awards, accounting for 83% of the total pay in 2021.
Carmer also received $195.7K in bonus, $509.2K in salary and $9K in other compensation.
Rankings
In 2021, Scott Carmer's compensation ranked 3,088th out of 12,415 executives tracked by ExecPay. In other words, Carmer earned more than 75.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,088 out of 12,415 | 75th |
Division Manufacturing | 1,239 out of 5,505 | 78th |
Major group Chemicals And Allied Products | 499 out of 2,375 | 79th |
Industry group Drugs | 441 out of 2,096 | 79th |
Industry Pharmaceutical Preparations | 301 out of 1,546 | 81st |
Source: SEC filing on May 3, 2022.
Carmer's colleagues
We found three more compensation records of executives who worked with Scott Carmer at NexImmune in 2021.